Coloplast A/S

OTC
CLPBF
Stock
Yield per half year: -11.57%
Dividend yield: 2.66%
Sector: Healthcare

Company Analysis Coloplast A/S

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (100 $) is less than fair price (114.25 $)
  • Dividends (2.66%) are higher than the sector average (2.28%).
  • The company's current efficiency (ROE=28.67%) is higher than the sector average (ROE=12.46%)

Disadvantages

  • The stock's return over the last year (-22.24%) is lower than the sector average (-3.67%).
  • Current debt level 47.07% has increased over 5 years from 1.38%.

Similar companies

Eisai Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Astellas Pharma Inc.

Roche Holding

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Coloplast A/S Healthcare Index
7 days 6.5% -7.9% 0.6%
90 days 1.4% -8.9% 19.2%
1 year -22.2% -3.7% 14.2%

CLPBF vs Sector: Coloplast A/S has significantly underperformed the "Healthcare" sector by -18.57% over the past year.

CLPBF vs Market: Coloplast A/S has significantly underperformed the market by -36.41% over the past year.

Stable price: CLPBF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.

Long period: CLPBF with weekly volatility of -0.4277% over the past year.

3. Summary of the report

3.1. General

P/E: 39.1
P/S: 7.31

3.2. Revenue

EPS 22.46
ROE 28.67%
ROA 10.5%
ROIC 0%
Ebitda margin 31.37%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (100 $) is lower than the fair price (114.25 $).

Price not significantly lower than the fair price: The current price (100 $) is slightly lower than the fair price by 14.3%.

4.2. P/E

P/E vs Sector: The company's P/E (39.1) is lower than that of the sector as a whole (54.24).

P/E vs Market: The company's P/E (39.1) is lower than that of the market as a whole (59.87).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (11.01) is higher than that of the sector as a whole (4.2).

P/BV vs Market: The company's P/BV (11.01) is higher than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (7.31) is higher than that of the sector as a whole (4.62).

P/S vs Market: The company's P/S indicator (7.31) is higher than that of the market as a whole (3.43).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (25.87) is higher than that of the sector as a whole (14.71).

EV/Ebitda vs Market: The company's EV/Ebitda (25.87) is lower than that of the market as a whole (40.12).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 4.07% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.07%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.5351%).

5.4. ROE

ROE vs Sector: The company's ROE (28.67%) is higher than that of the sector as a whole (12.46%).

ROE vs Market: The company's ROE (28.67%) is lower than that of the market as a whole (41.73%).

5.5. ROA

ROA vs Sector: The company's ROA (10.5%) is higher than that of the sector as a whole (6.23%).

ROA vs Market: The company's ROA (10.5%) is lower than that of the market as a whole (29.55%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.99%).

6. Finance

6.1. Assets and debt

Debt level: (47.07%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 1.38% to 47.07%.

Excess of debt: The debt is not covered by net income, percentage 447.92%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 2.66% is higher than the average for the sector '2.28%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 2.66% has been steadily paid over the past 7 years, DSI=0.86.

Weak dividend growth: The company's dividend yield 2.66% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (93.43%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Coloplast A/S

9.3. Comments